PubRank

Ernst Schering Research Foundation workshop (Ernst Schering Res Found Workshop)

Journal PubWeight™ 161.63‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Graph-based analysis of metabolic networks. 2002 1.35
2 Cluster analysis and its applications to gene expression data. 2002 1.06
3 TNF blockade: an inflammatory issue. 2006 0.99
4 The role of histone modifications in epigenetic transitions during normal and perturbed development. 2006 0.96
5 Saturation transfer difference NMR spectroscopy for identifying ligand epitopes and binding specificities. 2004 0.95
6 Microglia and the response to brain injury. 2002 0.94
7 Inflammation in stroke: the good, the bad, and the unknown. 2004 0.93
8 SEGRAs: a novel class of anti-inflammatory compounds. 2002 0.91
9 Role of hepatitis C virus in cardiomyopathies. 2006 0.90
10 New non-invasive approaches for the diagnosis of cardiomyopathy: magnetic resonance imaging. 2006 0.89
11 AAV vectors, the future workhorse of human gene therapy. 2003 0.89
12 [18F]fluoropyridines: From conventional radiotracers to the labeling of macromolecules such as proteins and oligonucleotides. 2007 0.89
13 Histone acetylation-mediated chromatin compaction during mouse spermatogenesis. 2006 0.89
14 Human endocervical mucins. 2005 0.88
15 Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases. 2006 0.88
16 Target analysis: a priori assessment of druggability. 2003 0.87
17 Lysosomal cysteine proteases and antigen presentation. 2006 0.87
18 High relaxivity contrast agents for MRI and molecular imaging. 2005 0.87
19 A plea for more theory in molecular biology. 2007 0.86
20 From classical mouse models of psoriasis to a spontaneous xenograft model featuring use of AGR mice. 2005 0.86
21 Polycomb silencing mechanisms and genomic programming. 2006 0.86
22 Drug discovery at signaling interfaces. 2003 0.86
23 Hedgehog signaling in animal development and human disease. 2000 0.86
24 Interplay of the SUMO and MAP kinase pathways. 2006 0.86
25 How is epigenetic information on chromatin inherited after DNA replication? 2006 0.85
26 Fluorine-18 labeling methods: Features and possibilities of basic reactions. 2007 0.85
27 Enzymatic incorporation of halogen atoms into natural compounds. 2005 0.85
28 Synthesis modules and automation in F-18 labeling. 2007 0.85
29 Induction of immunity and inflammation by interleukin-12 family members. 2006 0.85
30 Fluorine-18 labeling of peptides and proteins. 2007 0.85
31 Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. 2000 0.85
32 Statistical methods for analyzing gene expression data for cancer research. 2002 0.85
33 Matrix metalloproteinases in neuroinflammation and cerebral ischemia. 2004 0.84
34 Exploratory IND: a new regulatory strategy for early clinical drug development in the United States. 2007 0.84
35 Role of ubiquitin-like proteins in transcriptional regulation. 2006 0.84
36 The applications of biomarkers in early clinical drug development to improve decision-making processes. 2007 0.84
37 Eph receptors and ephrins are key regulators of morphogenesis. 2000 0.83
38 Histone post-translational modifications regulate transcription and silent chromatin in Saccharomyces cerevisiae. 2006 0.83
39 Involvement of tight junctions during transendothelial migration of mononuclear cells in experimental autoimmune encephalomyelitis. 2004 0.83
40 The theory of biological robustness and its implication in cancer. 2007 0.83
41 Elucidating molecular mechanisms of Alzheimer's disease in microglial cultures. 2002 0.83
42 Micro-reactors for PET tracer labeling. 2007 0.83
43 Polyketide synthases: mechanisms and models. 2005 0.83
44 68Ga-PET radiopharmacy: A generator-based alternative to 18F-radiopharmacy. 2007 0.83
45 Dendritic cell interactions and cytokine production. 2006 0.83
46 Nucleosome structure and function. 2006 0.83
47 The role of TNFalpha and IL-17 in the development of excess IL-1 signaling-induced inflammatory diseases in IL-1 receptor antagonist-deficient mice. 2006 0.82
48 Structural basis for substrate recognition and control in protein kinases. 2001 0.82
49 Interactions of selectins with PSGL-1 and other ligands. 2004 0.82
50 Induction and repression of NF-kappa B-driven inflammatory genes. 2002 0.82
Next 50